0001562180-20-006997.txt : 20201201
0001562180-20-006997.hdr.sgml : 20201201
20201201214326
ACCESSION NUMBER: 0001562180-20-006997
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201127
FILED AS OF DATE: 20201201
DATE AS OF CHANGE: 20201201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Woock John
CENTRAL INDEX KEY: 0001756437
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38721
FILM NUMBER: 201362279
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Axonics Modulation Technologies, Inc.
CENTRAL INDEX KEY: 0001603756
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 454744083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-396-6322
MAIL ADDRESS:
STREET 1: 26 TECHNOLOGY DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2020-11-27
false
0001603756
Axonics Modulation Technologies, Inc.
AXNX
0001756437
Woock John
26 TECHNOLOGY DRIVE
IRVINE
CA
92618
false
true
false
false
Chief Marketing Officer
Common Stock
2020-11-27
4
M
false
10000.00
1.42
A
77348.00
D
Common Stock
2020-11-27
4
S
false
2400.00
43.7946
D
74948.00
D
Common Stock
2020-11-27
4
S
false
100.00
45.49
D
74848.00
D
Common Stock
2020-11-27
4
S
false
7500.00
44.9414
D
67348.00
D
Stock Option (Right to Buy)
1.42
2020-11-27
4
M
false
10000.00
0.00
D
2027-08-25
Common Stock
10000.00
4178.00
D
This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 22, 2020.
This transaction was executed in multiple trades at prices ranging from $43.36 to $44.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $44.47 to $45.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The shares subject to the option vest over a period of four years. 7,800 of the shares subject to the option vested on July 21, 2017 and the remainder vest at a rate of 1/36th per month commencing on July 21, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable.
/s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D
2020-12-01